QuiaPEG Pharmaceuticals Holding AB
Save
3.83M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products.

Similar securities

Based on sector and market capitalization

Report issue